🇺🇸 FDA
Patent

US 10093654

Therapeutically active compounds and their methods of use

granted A61KA61K31/444A61K31/53

Quick answer

US patent 10093654 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
70
CPC classes
A61K, A61K31/444, A61K31/53, A61K9/2054, A61K9/2059